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Summary
Objectives:  Posttraumatic  stress  disorder  (PTSD)  prospectively  increases  the  risk  of  incident
cardiovascular  disease  (CVD)  independent  of  other  risk  factors  in  otherwise  healthy  individuals.
Between  10%  and  20%  of  patients  develop  PTSD  related  to  the  traumatic  experience  of  myocar-
dial infarction  (MI).  We  investigated  the  hypothesis  that  PTSD  symptoms  caused  by  MI  predict
adverse cardiovascular  outcome.
Methods:  We  studied  297  patients  (61  ±  10  years,  83%  men)  who  self-rated  PTSD  symptoms
attributable  to  a  previous  index  MI.  Non-fatal  CVD-related  hospital  readmissions  (i.e.  recurrent
MI, elective  and  non-elective  intracoronary  stenting,  bypass  surgery,  pacemaker  implantation,
cardiac  arrhythmia,  cerebrovascular  event)  were  assessed  at  follow-up.  Cox  proportional  hazard
models controlled  for  demographic  factors,  coronary  heart  disease  severity,  major  CVD  risk
factors, cardiac  medication,  and  mental  health  treatment.
Results:  Forty-three  patients  (14.5%)  experienced  an  adverse  event  during  a  mean  follow-up  of
2.8 years  (range  1.3—3.8).  A  10  point  higher  level  in  the  PTSD  symptom  score  (mean  8.8  ±  9.0,
range 0—47)  revealed  a  hazard  ratio  (HR)  of  1.42  (95%  CI  1.07—1.88)  for  a  CVD-related  hospital
readmission  in  the  fully  adjusted  model.  A  similarly  increased  risk  (HR  1.45,  95%  CI  1.07—1.97)
emerged for  patients  with  a  major  or  unscheduled  CVD-related  readmission  (i.e.  when  excluding
patients with  elective  stenting).
∗ Corresponding author at: Department of General Internal Medicine & Psychocardiology Unit, Inselspital, Bern University Hospital,
CH-3010 Bern, Switzerland. Tel.: +41 031 632 20 19; fax: +41 031 382 11 84.
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Conclusions:  Elevated  levels  of  PTSD  symptoms  caused  by  MI  may  adversely  impact  non-fatal
cardiovascular  outcome  in  post-MI  patients  independent  of  other  important  prognostic  factors.
The possible  importance  of  PTSD  symptoms  as  a  novel  prognostic  psychosocial  risk  factor  in
post-MI patients  warrants  further  study.
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Assessment  of  patient  characteristics© 2011  Japanese  College  of  C
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etween  10%  and  20%  of  patients  develop  posttraumatic
tress  disorder  (PTSD)  in  the  aftermath  of  acute  myocar-
ial  infarction  (MI)  [1—4]. To  meet  the  diagnostic  criteria
or  PTSD  according  to  the  fourth  edition  of  the  Diagnos-
ic  and  Statistical  Manual  of  Mental  Disorders  (DSM-IV)  [5],
atients  must  have  perceived  their  MI  as  an  event  involv-
ng  threatened  death  to  which  they  responded  with  intense
ear,  helplessness,  or  horror  (criterion  A).  Three  charac-
eristic  PTSD  symptom  clusters  (criteria  B,  C,  and  D)  must
e  present,  referring  to:  (a)  re-experiencing  of  MI,  e.g.  in
houghts  and  dreams;  (b)  avoidance  of  MI-related  stimuli,
.g.  intake  of  cardiac  medication;  and  (c)  hyperarousal,  e.g.
rritability  and  perturbed  sleep  [1].  These  clusters  of  symp-
oms  must  continue  for  at  least  one  month  during  which  they
nﬂict  clinically  signiﬁcant  distress  or  impairment  in  daily
unctioning.
Large-scale  epidemiologic  studies  found  PTSD  caused
y  different  types  of  trauma  increases  the  risk  of  inci-
ent  cardiovascular  disease  (CVD),  even  when  controlling
or  sociodemographic  factors,  major  CVD  risk  factors,  and
epression  [6—8]. In  contrast,  little  is  known  about  the
rognostic  value  of  PTSD  caused  by  MI  in  terms  of  cardiovas-
ular  outcome.  One  previous  study  investigated  65  post-MI
atients  of  which  13  qualiﬁed  for  PTSD  attributable  to  MI
eﬁned  by  above-threshold  PTSD  symptoms  (i.e.  PTSD  case-
ess)  on  the  Impact  of  Event  Scale  [9].  In  that  study,  case
eﬁnition  of  PTSD  predicted  hospital  readmissions  owing  to
VD  events,  including  recurrent  MI  and  unstable  angina,  at
ne-year  follow-up.  Therefore,  we  performed  a  prospective
tudy  on  cardiovascular  outcome  (i.e.  hospital  readmissions
ecause  of  CVD-related  events  and  procedures)  in  a  sizeable
ample  of  patients  with  a  previous  index  MI  who  self-rated
I-speciﬁc  PTSD  symptoms  at  study  entry.  We  hypothesized
hat  elevated  levels  of  PTSD  symptoms  caused  by  MI  would
ncrease  the  risk  of  a  non-fatal  CVD-related  hospital  read-
ission  independent  of  demographic  and  medical  covariates
hat  may  also  adversely  impact  the  prognosis  of  coronary
eart  disease.
aterials and methods
tudy  participants
he  study  protocol  was  approved  by  the  ethics  committee
f  the  Canton  of  Bern,  Switzerland.  All  participants  pro-
ided  written  informed  consent.  The  recruitment  procedure
f  post-MI  patients  has  previously  been  detailed  [4].  In  brief,
e  approached  consecutive  patients  referred  to  the  Depart-
ent  of  Cardiology,  Inselspital,  Bern  University  Hospital,
witzerland,  with  a  veriﬁed  index  ST-  and  non-ST-elevation
I.  All  patients  underwent  a  coronary  angiography  and  per-
W
r
rology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
utaneous  transluminal  coronary  angioplasty  of  the  culprit
esion.  When  indicated,  percutaneous  intervention  or  bypass
urgery  was  performed  in  a  second  step  to  full  revasculariza-
ion.  Further  eligibility  criteria  were  living  within  a  90-min
ide  from  the  University  Hospital  and  to  speak  German  suf-
ciently.  Within  one  year  of  their  index  MI,  the  383  patients
ho  participated  in  the  present  study  were  sent  the  Post-
raumatic  Diagnostic  Scale  (PDS;  cf.  below)  to  complete  at
ome  to  self-rate  the  level  of  PTSD  symptoms  (i.e.  post-
raumatic  stress)  caused  by  the  index  MI.  We  decided  to
ssess  posttraumatic  stress  over  a  variable  time  course  as
he  DSM-IV  distinguishes  between  several  sub-types  of  PTSD
ccording  to  a  time  criterion.  Speciﬁcally,  acute  PTSD  refers
o  symptoms  which  last  between  1  month  and  less  than
 months,  chronic  PTSD  refers  to  symptoms  lasting  3  months
r  longer,  and  delayed-onset  PTSD  refers  to  symptoms  that
egin  after  an  interval  of  at  least  6  months  after  the  trauma
5].  Although  repeated  assessments  of  posttraumatic  stress
ould  be  needed  to  assure  PTSD  subtypes,  we  judged  that
atient  enrolment  over  one  year  post-MI  might  yield  a  sam-
le  in  which  all  subtypes  of  PTSD  symptoms  are  represented.
For  the  follow-up,  all  initially  assessed  383  patients  were
ontacted  again  by  mail  and  asked  for  their  willingness  to
articipate  in  an  investigation  that  assessed  cardiovascular
utcome  since  completion  of  the  PDS.  Those  who  did  not
espond  to  the  ﬁrst  invitation  letter  were  sent  the  letter
gain.  Fifty-three  (13.8%)  of  the  original  383  patients  were
ost  to  follow-up,  47  for  different  reasons  (e.g.  not  respond-
ng  to  the  invitation  letter,  letter  returned  to  sender  because
f  unknown  address,  no  interest)  and  6  had  died  during
ollow-up.  We  excluded  the  deceased  patients  because  this
roup  was  too  small  for  a  meaningful  analysis.  An  addi-
ional  33  patients  (8.6%)  were  excluded  because  we  did  not
ave  complete  data  available  in  terms  of  CVD  risk  factors
nd  cardiac  medication.  When  these  missing  values  were
mputed  according  to  the  procedures  described  by  Schafer
10],  posttraumatic  stress  was  also  signiﬁcantly  predictive
f  CVD-related  hospital  readmissions  controlling  for  covari-
tes  (50  adverse  events  occurred  during  follow-up  in  the  330
atients  of  whom  33  had  some  imputed  data  points).  This
rocedure  left  a  ﬁnal  sample  of  297  patients  with  a  com-
lete  data  set  for  the  prospective  study  presented  here.  The
6  patients  who  were  either  lost  to  follow-up  or  had  miss-
ng  data  did  not  signiﬁcantly  differ  from  these  297  patients
n  terms  of  sex,  age,  PDS  score,  time  sending  out  PDS  after
ndex  MI,  recurrent  MI,  and  number  of  diseased  coronary
essels  (all  p-values  >0.38).e  abstracted  sex,  age,  type  of  index  MI  (ﬁrst-time  vs.
ecurrent  MI),  the  number  of  diseased  coronary  vessels,  CVD
isk  factors,  and  cardiac  medication  from  hospital  charts
Posttraumatic  stress  and  cardiovascular  prognosis  
Table  1  The  17-item  Posttraumatic  Diagnostic  Scale  asking
about  index  myocardial  infarction  as  the  traumatic  event.
PTSD  symptom  cluster  B:  re-experiencing  MI  as  a
traumatic  event
1.  Intrusive  images  about  MI
2.  Nightmares  about  MI
3.  Reliving  of  MI
4. Emotionally  upset  when  reminded  of  MI
5. Physical  reactions  when  reminded  of  MI
PTSD  symptom  cluster  C:  avoidance  of  MI  as  a  traumatic
event and  psychic  numbing
6. Trying  not  to  think,  talk,  or  have  feelings  about  MI
7. Trying  to  avoid  activities,  places,  or  people  that  remind
of MI
8.  Memory  loss  for  important  aspects  of  MI
9. Loss  of  interest  in  previously  enjoyed  activities
10. Feeling  distant  or  cut  off  from  other  people
11. Feeling  emotionally  numb
12. Sense  of  a  foreshortened  future
PTSD  symptom  cluster  D:  hyperarousal
13.  Sleeping  difﬁculties
14.  Irritability  or  outbursts  of  anger
15. Difﬁculty  concentrating  or  completing  tasks
16. Hypervigilance
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P17.  Exaggerated  startle  response
MI, myocardial infarction; PTSD, posttraumatic stress disorder.
which  refer  to  the  time  of  the  index  MI.  Hypertension
was  deﬁned  by  a  positive  history  for  treatment  or  systolic
and/or  diastolic  blood  pressure  ≥140/90  mm  Hg  at  rest.  Dia-
betes  was  deﬁned  by  a  positive  history  that,  if  unclear,  was
veriﬁed  by  one-time  glucose  level  >200  mg/dL.  The  status
of  current  smoking  (yes/no)  was  also  obtained  from  the
charts.  The  use  (yes/no)  of  aspirin,  statins,  beta  blockers,
and  angiotensin-converting  enzyme  (ACE)  inhibitors  was  also
noted.
Assessment  of  posttraumatic  stress  symptoms
We  used  the  validated  German  version  of  the  PDS,  which  is  a
self-report  measure  comprising  17  questions  mapping  onto
DSM-IV  symptoms  for  PTSD  [11,12].  There  was  good  internal
consistency  in  our  sample  of  post-MI  patients  for  the  total
PDS  score  (Cronbach’s  ˛  =  91)  and  the  3  PTSD  symptom  clus-
ter  scores  (criteria  B,  C,  and  D)  of  re-experiencing  (˛  =  .88),
avoidance/numbing  (˛  =  .80),  and  hyperarousal  (˛  =  .76).  In
the  questionnaire  we  replaced  the  term  ‘‘event’’  with  the
term  ‘‘heart  attack’’  [2].  Patients  rated  on  a  4-point  scale
how  often  they  had  experienced  each  symptom  during  the
past  month  (0  =  not  at  all,  3  =  often)  yielding  a  PTSD  symptom
severity  score  between  0  and  51  (re-experiencing:  0—15,
avoidance:  0—21,  hyperarousal:  0—15).  Missing  items  were
replaced  with  the  mean  of  completed  items  of  the  respec-
tive  symptom  cluster.  Table  1  summarizes  the  17  items  of
the  PDS  according  to  symptom  clusters  B—D  of  PTSD  [11].
The  PDS  performs  well  as  a  screening  tool  to  identify  clin-
ical  cases  of  PTSD  [13]. A  total  PDS  score  ≥18  recently
yielded  the  best  balance  between  sensitivity  and  speciﬁcity
for  screening  for  PTSD  (i.e.  PTSD  caseness)  across  differ-
s
i
t
o63
nt  samples  of  trauma  survivors  (area  under  the  receiver
perating  characteristic  curve  0.90—0.96)  [14].
The PDS  does  not  assess  the  DSM-IV  criterion  A2  for  PTSD,
.e.  to  what  extent  the  patients  responded  to  the  A1  event
i.e.  the  MI)  with  ‘‘intense  fear,  helplessness,  or  horror’’.
herefore,  at  the  time  when  they  completed  the  PDS,  we
sked  the  patients  to  retrospectively  rate  on  a  numeric  scale
‘fear  of  dying’’  and  ‘‘feelings  of  helplessness’’  they  had
erceived  during  MI.  Speciﬁc  items  were  (0  =  absolutely  not
rue,  10  =  absolutely  true)  [2]:  ‘‘During  my  referral  to  the
ospital,  the  emergency  unit,  or  the  intensive  care  unit,  I
as  afraid  I  was  dying,’’  and  ‘‘When  the  doctor  told  me  I
ad  a  heart  attack,  I  was  frightened,  felt  helpless,  and  was
fraid  of  losing  control  over  the  situation.’’
ssessment  at  follow-up
he  follow-up  period  referred  to  the  time  interval  between
ending  out  the  PDS  to  assess  PTSD  symptoms  in  relation
o  the  index  MI  and  a  semi-structured  telephone  inter-
iew  by  using  a  standard  protocol.  During  the  interview
atients  were  asked  whether  they  had  been  hospitalized
ecause  of  a  new  CVD  event  or  CVD-related  intervention.
e  assessed  the  following  speciﬁc  diagnostic  categories  and
nterventions  by  using  a  checklist  (yes/no  answers):  recur-
ent  MI,  elective  and  non-elective  intracoronary  stenting,
oronary  artery  bypass  surgery,  pacemaker  implantation,
ardiac  arrhythmia,  cardiac  arrest,  cerebrovascular  insult,
ransient  ischemic  attack,  hypertensive  crisis,  and  chronic
eart  failure.  If  patients’  self-report  about  the  cardiovascu-
ar  cause  for  hospitalization  was  non-speciﬁc,  their  primary
are  physicians  were  contacted  by  telephone  to  verify  the
ype  of  CVD-related  event  or  intervention  (all  contacted
hysicians  could  be  reached).  We  did  not  consider  ‘‘angina
ectoris’’  as  a  diagnostic  category  because  chest  pain  has
any  cardiac  and  non-cardiac  causes,  one  being  psychologi-
al  distress  that  is  particularly  high  in  traumatized  subjects.
owever,  recurrence  of  chest  pain  previously  predicted
osttraumatic  stress  in  patients  12  months  after  hospital
dmission  for  an  acute  coronary  syndrome  [15]. We  thus
sked  about  chest  pain  which  had  occurred  since  index  MI
aving  prompted  patients  to  see  a  doctor  but  remained
nexplained.  We  further  asked  patients  whether  they  had
eceived  mental  health  treatment  in  the  form  of  antide-
ressant  medication  and/or  psychotherapy  since  the  index
I.
tatistical  analysis
ata  were  analyzed  using  SPSS  15.0  statistical  software
ackage  (SPSS  Inc.,  Chicago,  IL,  USA)  with  a  signiﬁcance
evel  of  p  <  0.05  (two-tailed).  For  calculations  of  differences
etween  groups,  Student’s  t  test,  Pearson  chi-square  test,
nd  Fisher’s  exact  test  were  used  where  appropriate.  We
an  Cox  proportional  hazard  models  to  estimate  the  predic-
ive  value  of  posttraumatic  stress  severity  (assessed  by  the
DS  at  study  entry)  for  the  relative  risk  of  a  hospital  readmis-
ion  during  follow-up  because  of  a  CVD  event  or  CVD-related
ntervention  (combined  endpoint).  For  this  analysis  we  used
he  total  PDS  score  as  a  continuous  variable  (i.e.  the  PDS  cut-
ff  ≥18  was  only  used  to  compute  the  prevalence  of  PTSD
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14  
aseness  and  to  compare  characteristics  between  patients
ith  high  versus  low  PDS  scores).  Total  PDS  scores  showed
 skewed  distribution  towards  small  values.  Although  not
ormally  distributed  predictor  variables  have  generally  no
mpact  on  regression-type  models  [16], we  reran  all  mod-
ls  with  normally  distributed  square  root  transformed  total
DS  scores;  this  procedure  did  not  change  the  signiﬁcance
f  posttraumatic  stress  as  a  predictor  of  CVD-related  out-
ome  (data  not  shown).  Because  a  one  point  higher  level  on
DS  scores  predicts  a  change  in  the  relative  risk  [the  term
‘relative  risk’’  refers  to  the  hazard  ratio  (HR)  throughout
he  manuscript]  that,  even  when  being  statistically  signif-
cant,  is  unlikely  of  clinical  relevance,  we  expressed  the
hange  in  the  HR  with  95%  conﬁdence  interval  (CI)  for  a
0  point  higher  level  on  the  total  PDS  score  and  for  a  3
oint  higher  level  on  the  individual  PTSD  symptom  scores.
or  this  purpose  total  PDS  scores  and  individual  PTSD  symp-
om  scores  were  divided  by  10  and  3,  respectively,  prior  to
ntering  them  into  the  models.
Control  variables  that  might  potentially  affect  CHD
utcome  were  deﬁned  a  priori, whereby  sex  and  age  (demo-
raphic  factors)  were  treated  as  control  variables  in  all
odels.  To  prevent  over-ﬁtted  models  given  the  number
f  endpoint  events  [16], we  ﬁrst  identiﬁed  potentially  rel-
vant  predictors  of  outcome.  Together  with  sex  and  age,
hese  were  grouped  into  ﬁve  separate  blocks  of  covariates:
1)  CHD  severity:  type  of  the  index  MI  (ﬁrst-time  vs.  recur-
ent  MI),  number  (1,  2,  or  3)  of  diseased  coronary  vessels;
2)  major  CVD  risk  factors:  hypertension,  diabetes,  cur-
ent  smoking  (all  coded  as  yes/no);  (3)  cardiac  medication
rescribed  at  hospital  discharge:  aspirin,  statins,  beta  block-
rs,  ACE  inhibitors  (all  coded  as  yes/no);  (4)  unexplained
hest  pain  since  index  MI  (coded  as  yes/no);  and  (5)  mental
ealth  treatment  since  index  MI:  antidepressant  medication,
sychotherapy  (both  coded  as  yes/no).  Control  variables
merging  as  outcome  predictors  (p  <  0.10)  from  these  ﬁve
locks  were  entered  into  the  ﬁnal  model  together  with  sex,
ge,  and  posttraumatic  stress  (one  block).
esults
atient  characteristics
he  mean  ±  SD  time  since  index  MI  the  PDS  was  sent  was
6  ±  59  days  (range  12—365);  to  278  patients  (93.6%)  the
DS  was  sent  between  1  and  6  months  post-MI.  Across  all
97  post-MI  patients,  total  PDS  score  was  8.8  ±  9.0  (range
—47),  fear  of  dying  score  was  2.8  ±  3.2  (range  0—10),  and
elplessness  score  was  3.0  ±  3.2  (range  0—10).  Total  PTSD
ymptoms  correlated  with  fear  of  dying  (r  =  0.57,  p  <  0.001)
nd  helplessness  (r  =  0.65,  p  <  0.001)  suggesting  that,  in
greement  with  the  DSM-IV  criterion  A  of  PTSD,  patients
ith  greater  posttraumatic  stress  responded  to  the  MI  with
ore  intense  fear,  helplessness,  or  horror  [5].  Most  fre-
uently  reported  PTSD-speciﬁc  symptoms  of  re-experiencing
I-related  events  (range  0—3)  were  intrusive  images  about
I  (0.82  ±  0.88)  and  emotional  upset  when  reminded  of  MI
0.75  ±  0.87);  reliving  of  MI  (0.44  ±  0.71),  physical  reactions
hen  reminded  of  MI  (0.41  ±  0.76),  and  nightmares  about  MI
0.29  ±  0.66)  were  comparably  less  often  named.
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Forty-ﬁve  patients  (15.2%)  met  case  deﬁnition  criteria
or  PTSD  according  to  a PDS  score  ≥18  [13]. Table  2  shows
he  characteristics  of  patients  according  to  high  (PDS  score
18)  versus  low  (PDS  score  <18)  levels  of  PTSD  symptoms.
ompared  to  patients  with  low  levels  of  PTSD  symptoms,
hose  with  high  levels  reported  greater  fear  of  dying  and
elplessness,  were  more  often  female  and  younger,  but  had
ess  severe  CHD  with  regard  to  the  number  of  diseased  coro-
ary  vessels.  Other  major  CVD  risk  factors  and  prescription
f  cardiac  medications  did  not  differ  between  groups.  During
ollow-up,  patients  fulﬁlling  PTSD  criteria  were  more  likely
o  have  received  mental  health  treatment  than  patients  not
ulﬁlling  PTSD  criteria.
dverse  cardiovascular  events  during  follow-up
he  mean  duration  of  follow-up  was  2.8  years  (range
.3—3.8)  during  which  a  CVD-related  hospital  readmission
ccurred  in  43  (14.5%)  of  the  297  post-MI  patients  who
ere  available  for  follow-up.  The  43  CVD-related  events  or
nterventions  were  10  (3.4%)  recurrent  MIs,  13  (4.4%)  non-
lective  stents,  11  (3.7%)  elective  stents,  4  (1.3%)  coronary
rtery  bypass  surgeries,  1  (0.3%)  pacemaker  implantation,
 (0.3%)  cardiac  arrhythmia,  and  3  (1.0%)  cerebrovascular
vents.  There  were  no  hospital  readmissions  because  of  car-
iac  arrest,  hypertensive  crisis,  or  chronic  heart  failure.
TSD  symptoms  and  CVD-related  hospital
eadmissions
able  3  shows  that  for  a  10  point  higher  level  in  the  PDS
core,  there  was  a  45%  to  51%  higher  relative  risk  of  a  CVD-
elated  hospital  readmission  with  adjustments  for  the  ﬁve
locks  of  covariates.  From  these  blocks  of  covariates,  hyper-
ension  status  (HR  2.51,  95%  CI  1.19—5.31)  emerged  as  the
nly  independent  predictor  of  the  outcome.  The  ﬁnal  model
howed  a  42%  higher  relative  risk  of  a  CVD-related  hospital
eadmission  with  a  10  point  higher  level  in  posttraumatic
tress  controlled  for  sex,  age,  and  hypertension.  Fig.  1  illus-
rates  the  survival  curves  across  quartiles  of  continuous  PTSD
cores.  In  terms  of  individual  PTSD  symptom  scores,  there
merged  a  29%  higher  relative  risk  of  a  CVD-related  hospi-
al  readmission  for  a  3  point  higher  level  in  re-experiencing
ymptoms,  controlling  for  sex,  age,  and  hypertension  (HR
.29,  95%  CI  1.01—1.65).  Similar  risks  were  revealed  for  a  3-
oint  higher  level  in  symptoms  of  avoidance  (HR  1.27,  95%  CI
.04—1.55)  and  of  hyperarousal  (HR  1.33,  95%  CI  1.03—1.71).
Table  3  shows  a  complementary  analysis  for  which  we
nly  considered  major  and  unscheduled  CVD-related  hos-
ital  readmissions.  In  other  words,  we  excluded  the  11
atients  who  underwent  elective  stenting  during  follow-up.
ypertension  status  was  the  only  independent  predictor  of
utcome  (HR  3.77,  95%  CI  1.43—9.97).  In  the  fully  adjusted
odel,  the  relative  risk  for  an  adverse  event  was  45%  for  a
0  point  higher  level  in  the  PDS  score.  The  relative  risk  of
n  adverse  event  was  39%,  27%,  and  33%,  respectively,  for
 3  point  higher  level  in  symptom  scores  of  reexperiencing
HR  1.39,  95%  CI  1.07—1.80),  avoidance  (HR  1.27,  95%  CI
.02—1.58),  and  hyperarousal  (HR  1.33,  95%  CI  1.00—1.76).
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Table  2  Characteristics  of  297  patients  per  PTSD  symptom  level.
Variable  High  PDS  score  (n  =  45)  Low  PDS  score  (n  =  252)  p-Value
Total  PTSD  symptoms  (score)  25.9  ±  7.4  5.8  ±  4.9  <0.001
Re-experiencing  symptoms  (score)  8.3  ±  3.5  1.7  ±  1.9  <0.001
Avoidance symptoms  (score)  10.3  ±  3.5  2.0  ±  2.1  <0.001
Hyperarousal  symptoms  (score)  7.3  ±  3.4  2.0  ±  2.1  <0.001
Fear of  dying  during  MI  (score)  6.1  ±  3.1  2.2  ±  2.8  <0.001
Feelings of  helplessness  during  MI  (score) 6.8  ±  2.5  2.3  ±  2.8  <0.001
Women (%) 28.9 15.1  0.031
Age (years) 55.7  ±  7.6 61.7  ±  10.7 <0.001
Time since  index  MI  PDS  was  sent  (days) 83.9  ±  59.4 74.2  ±  59.1 0.331
Recurrent  MI  (%) 8.9 9.1 1.000
1-, 2-,  3-vessel  disease  (%)  64,  27,  9  41,  32,  27  0.006
Hypertension  (%)  64.4  61.5  0.742
Diabetes (%)  17.8  11.5  0.229
Current smoker  (%)  51.1  38.1  0.101
Aspirin (%)  100  98.4  1.000
Statin (%)  100  96.4  0.364
Beta blocker  (%)  97.8  91.3  0.222
Angiotensin-converting  enzyme  inhibitor  (%)  60.0  70.6  0.155
Chest pain  since  index  MI  (%)  4.4  3.2  0.652
Antidepressant  therapy  since  index  MI  (%)  26.7  8.3  0.001
Psychotherapy  since  index  MI  (%)  17.8  6.7  0.035
isord
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lPDS, Posttraumatic Diagnostic Scale; PTSD, posttraumatic stress d
Sensitivity  analyses
To  test  for  the  robustness  of  the  above  ﬁndings  we  per-
formed  ﬁve  sensitivity  analyses.  We  restrict  the  presentation
of  the  results  to  the  fully  adjusted  models,  which  controlled
for  sex,  age,  and  hypertension  status.  All  HRs  refer  to  the
increase  in  the  relative  risk  of  a  CVD-related  hospital  read-
mission  for  a  10-point  higher  level  in  the  total  PDS  score  for
the  respective  subsample.
w
2
p
Table  3  Multivariate  relative  risk  for  future  adverse  cardiovasc
Diagnostic Scale  score  (hazard  ratio,  95%  CI).
Control  variablesa CVD-related  readmissi
(n =  297,  43  events)
CHD  severity  1.50  (1.13—1.98)  
CVD risk  factors  1.51  (1.12—2.03)  
Cardiac medication  1.45  (1.09—1.93)  
Unexplained  chest  pain  1.45  (1.10—1.92)  
Mental health  treatment  1.46  (1.10—1.95)  
Final model
Female  sex  0.42  (0.15—1.18)  
Age 1.01  (0.98—1.04)  
Hypertension  2.34  (1.12—4.90)  
Posttraumatic  stress  1.42  (1.07—1.88)  
a All models controlled a priori for sex and age. Additional predictor
separate blocks. Coronary heart disease (CHD) severity: number of d
Cardiovascular disease (CVD) risk factors: hypertension, diabetes, cur
angiotensin-converting enzyme inhibitor. Unexplained chest pain: had
health treatment: antidepressant medication, psychotherapy. Final mo
positive history of hypertension both coded as ‘‘1’’).er; MI, myocardial infarction.
First  analysis:  We  controlled  for  the  time  between  index
I  and  sending  out  the  PDS  to  account  for  the  possibility  that
onger  duration  of  PTSD  symptoms  affects  CVD  outcome:  HR
.44,  95%  CI  1.08—1.91  (n  =  297;  45  with  high  PTSD  symptom
evels;  43  events).Second  analysis:  We  excluded  21  patients  (7.1%)  who
ere  sent  the  PDS  earlier  than  30  days  (i.e.  between  12  and
9  days)  after  the  index  MI  to  consider  only  those  partici-
ants  who  clearly  fulﬁlled  the  time  criterion  for  PTSD  (i.e.
ular  events  for  a  10  point  higher  level  in  the  Posttraumatic
ons CVD-related  readmissions  without
elective  stents  (n  =  286,  32  events)
1.56  (1.15—2.12)
1.57  (1.13—2.18)
1.48  (1.09—2.02)
1.51  (1.11—2.04)
1.54  (1.13—2.09)
0.28  (0.07—1.16)
1.00  (0.96—1.04)
3.47  (1.33—9.06)
1.45  (1.07—1.97)
s (p < 0.10) to be included in the ﬁnal model were tested in ﬁve
iseased coronary vessels, recurrent myocardial infarction (MI).
rent smoking. Cardiac medication: statin, aspirin, beta blocker,
 occurred since index MI and prompted physician visit. Mental
del: all four variables were entered in one block (female sex and
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Figure  1  Survival  function  for  quartiles  (Q)  of  posttraumatic
stress  symptom  severity  rated  by  the  Posttraumatic  Diagnostic
Scale (PDS).  PDS  scores  were  0.7  ±  0.8  for  Q1  (n  =  68,  9  events),
3.9 ±  0.8  for  Q2  (n  =  56,  7  events),  8.6  ±  2.3  for  Q3  (n  =  72,  12
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tvents),  and  21.8  ±  7.8  for  Q4  (n  =  58,  15  events).  Adjustment
as made  for  sex,  age,  and  hypertension.
ymptom  duration  of  at  least  one  month):  HR  1.45,  95%  CI
.08—1.94  (n  =  276,  45  with  high  PTSD  symptom  levels;  39
vents).
Third  analysis:  We  excluded  19  patients  (6.4%)  who  were
ent  the  PDS  more  than  half  a  year  after  their  index  MI  (i.e.
etween  182  and  365  days)  to  account  for  the  skewed  dis-
ribution  of  this  time  interval:  HR  1.46,  95%  CI  1.08—1.98
n  =  278,  41  with  high  PTSD  symptom  levels;  40  events).
Fourth  analysis:  We  excluded  3  patients  (1.0%)  who  indi-
ated  a  CVD-related  hospital  readmission  in  the  same  month
n  which  they  also  completed  the  PDS  to  account  for  the
ossibility  that  the  event  unduly  affected  the  PDS  score:  HR
.45,  95%  CI  1.08—1.94  (n  =  294,  45  with  high  PTSD  symptom
evels;  40  events).
Fifth  analysis:  We  excluded  the  33  patients  with  antide-
ressant  medication  to  test  whether  the  association  of
osttraumatic  stress  with  CVD-related  hospital  readmissions
as  independent  of  this  surrogate  of  depressive  symptoms:
R  of  1.41,  95%  CI  1.02—1.95  (n  =  264;  33  with  high  PTSD
ymptom  levels;  37  events).
iscussion
e  found  that  elevated  levels  of  PTSD  symptoms  caused  by
I  predicted  the  risk  of  future  hospital  readmissions  due  to  a
ombined  endpoint  of  non-fatal  CVD  events  and  CVD-related
nterventions  over  a  mean  follow-up  period  of  almost  three
ears.  This  relationship  was  independent  of  several  other
otential  predictors  of  adverse  outcome.  Results  from  ﬁve
ensitivity  analyses  suggested  the  predictive  value  of  post-
raumatic  stress  for  future  non-fatal  CVD-related  hospital
eadmissions  is  robust.  We  further  found  that  PTSD  symp-
e
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oms  predicted  poor  cardiovascular  outcome  even  when
lective  intracoronary  stenting  was  not  considered  as  an  out-
ome.  This  may  suggest  that  including  elective  stenting  in
ur  combined  outcome  did  not  dilute  the  ‘‘true’’  time  inter-
al  after  which  hospital  readmission  became  inevitable  due
o  the  progression  of  CHD.
Our  ﬁndings  suggest  that  the  risk  of  adverse  CVD-related
utcome  of  post-MI  patients  lies  along  a  continuum  of  PTSD
ymptom  severity.  Speciﬁcally,  in  the  ﬁnal  multivariate-
djusted  primary  analysis,  a  10  point  higher  level  in  the  PDS
core  showed  an  increase  of  42%  in  the  relative  risk  for  a
VD-related  event.  Moreover,  15.2%  of  MI  survivors  met  a
DS  cut-off  score  ≥18  which  previously  performed  well  as
 screening  tool  for  PTSD  caseness  in  individuals  with  non-
I  related  traumas  [14]. This  prevalence  of  PTSD  caseness
argely  concurs  with  that  found  in  other  samples  of  post-MI
atients  investigated  in  the  ﬁrst  year  after  MI  [1],  but  it  is
everal  times  higher  than  the  12-month  prevalence  of  PTSD
n  a  representative  Swiss  population  sample  [17].
Because  PTSD  caused  by  MI  is  frequent  and  clinically
mportant,  clinicians  may  want  to  routinely  assess  PTSD
ymptomatology  in  their  post-MI  patients,  even  though  it
s  currently  unknown  which  treatment  should  be  delivered
nd  whether  it  may  alleviate  cardiovascular  morbidity.  We
ound  that  patients  meeting  PTSD  caseness  criteria  were
ounger  and  seemed  to  have  less  severe  CHD  than  non-PTSD
ases.  Hence  it  might  be  that  the  relatively  younger  post-
I  patients  with  PTSD,  but  not  necessarily  those  with  more
evere  CHD,  particularly  beneﬁt  from  PTSD  treatment.  One
mall  study  showed  a  decrease  in  MI-caused  PTSD  symptoms
nd  CVD  risk  factor  status  after  trauma-focused  cognitive
ehavior  therapy  (CBT)  plus  education  compared  to  educa-
ion  alone  [18]. This  ﬁnding  is  in  line  with  the  established
nowledge  that  the  most  effective  psychotherapies  for  PTSD
re  those  focusing  on  the  psychological  trauma  [19]. Impor-
antly,  trauma-focused  CBT  seems  safe  in  patients  with  PTSD
esulting  from  cardiovascular  illness  (including  MI)  since
emodynamic  activity  does  not  evidently  increase  during
maginal  exposure  therapy  [20]. In  addition,  selective  sero-
onin  reuptake  inhibitors  (SSRIs)  in  sufﬁciently  high  doses
re  ﬁrst-line  drugs  to  treat  PTSD  [21]  and  SSRIs  (but  not  tri-
yclic  antidepressants,  TCAs)  are  also  safely  administered  to
atients  with  CHD  [22]. Interestingly  enough,  adjustments
or  psychotherapy  and  antidepressant  medication  did  not
educe  the  risk  of  adverse  outcome  in  relation  to  PTSD  symp-
oms  in  our  patients.  It  might  be  that  traumatic  experience
f  MI  was  not  speciﬁcally  addressed  in  those  psychotherapies
nd  that  the  dosage  of  antidepressants  was  too  low  to  alle-
iate  posttraumatic  stress.  However,  it  should  also  be  noted
hat  we  did  not  have  information  about  the  type  of  pre-
cribed  antidepressants.  Therefore,  we  cannot  exclude  the
ossibility  that  favorable  effects  of  SSRIs  on  cardiovascular
utcomes  were  outweighed  by  unfavorable  effects  of  TCAs
uch  that  the  overall  effect  of  antidepressants  was  null.
Atherosclerotic  mechanisms  underlie  the  vast  major-
ty  of  CVD  events  and  CVD-related  procedures  that  were
onsidered  as  outcomes  in  our  study.  Although  not  inves-
igated  here,  several  pathophysiologic  mechanisms  might
xplain  the  atherosclerotic  CVD  risk  associated  with  PTSD
ymptoms.  These  may  particularly  include  low-grade  sys-
emic  inﬂammation  [1].  Neuroendocrine  and  autonomic
lterations  in  PTSD  are  thought  to  mediate  a  dysfunctional
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peripheral  stress  response  involving  a  range  of  immuno-
logical  changes  with  the  associated  wear  and  tear  to
the  body  giving  rise  to  the  clinical  manifestation  of  CVD
and  atherothrombotic  events  [23,24].  There  is  particular
evidence  for  altered  hypothalamic—pituitary—adrenal  axis
function  involving  peripheral  hypocortisolemia  and  a  hyper-
adrenergic  state  in  PTSD  [25,26].  Plasma  levels  of  cortisol
were  lower  and  those  of  the  proinﬂammatory  cytokine
interleukin-6  were  higher  in  patients  with  PTSD  caused  by  MI
than  in  post-MI  patients  with  no  PTSD  [27,28].  Another  study
found  a  positive  correlation  between  plasma  norepinephrine
and  interleukin-6  levels  in  PTSD  related  to  combat  expo-
sure  [29]. Patients  with  PTSD  may  also  have  decreased
vagal  activity  [30]. Vagal  withdrawal  might  give  rise  to
enhanced  production  of  proinﬂammatory  cytokines  by  tissue
macrophages  [31], thereby  potentially  kindling  inﬂamma-
tion  in  coronary  arteries  [32].
We  mention  several  limitations  of  our  study.  The  link
between  PTSD  and  poor  prognosis  of  CHD  might  also  be  medi-
ated  by  low  adherence  to  cardiac  therapy  [33]  and  adverse
life  style  such  as  smoking,  excessive  alcohol  consumption,
low  physical  activity,  and  dietary  habits  promoting  dyslipi-
demia  and  overweight  [1].  We  controlled  for  current  smoking
and  statin  use  as  a  proxy  measure  of  hyperlipidemia,  but
we  had  no  information  available  about  adherence,  physical
activity,  diet,  and  body  mass  index  to  control  for  obesity.
However,  obesity  has  also  been  shown  to  be  associated
with  reduced  mortality  after  ST-elevation  MI  [34]  in  which
case  the  controlling  for  obesity  should  have  theoretically
strengthened  the  predictive  value  of  posttraumatic  stress
for  CVD-related  hospital  readmissions.  It  would  have  further
strengthened  our  study  if  we  had  also  taken  into  account
as  covariates  important  prognostic  factors  like  cholesterol
levels,  prevalence  of  pre-infarction  angina,  Killip  class,  left
ventricular  function,  and  peak  levels  for  cardiac  enzymes.
The  window  for  sending  the  questionnaire  was  one  year  such
that  we  cannot  fully  rule  out  that  some  cases  of  PSTD  that
resolved  before  the  assessment  was  made.  It  is  also  possible
that  more  severe  and  prolonged  chest  pain  before  MI  and
between  MI  and  PTSD  assessment  had  contributed  to  the
level  of  posttraumatic  stress  [15]. However,  we  adjusted
for  CHD  severity,  unexplained  chest  pain  since  index  MI,
and  the  time  interval  between  index  MI  and  PTSD  assess-
ment;  moreover,  the  prevalence  of  PTSD  did  previously  not
decrease  with  longer  time  elapsed  within  the  ﬁrst  year  since
MI  [1].  We  did  not  assess  other  psychosocial  risk  indicators
for  post-MI  prognosis  such  as  low  social  support  [35]  and
depression  [36]  both  of  which  are  also  associated  with  PTSD
in  cardiac  patients  [15,37].  However,  PTSD  symptoms  pre-
viously  predicted  incident  CVD  independent  of  depression
[6—8]  and  some  authors  argue  that  separating  out  depres-
sion  as  a  distinct  disorder  when  it  occurs  with  PTSD  more
than  one  year  after  trauma  is  an  arbitrary  distinction  [38].
Moreover,  we  found  that  PTSD  speciﬁc  symptoms  of  reex-
periencing  MI-related  cues  were  individually  predictive  of
poor  CVD-related  outcome.  Antidepressant  medication  (i.e.
a  surrogate  of  clinical  depression)  was  not  a  signiﬁcant
predictor  of  outcome  and  dropping  patients  with  antide-
pressant  medications  also  maintained  the  predictive  value  of
posttraumatic  stress.  Although  avoidance  and  hyperarousal
symptoms,  which  are  less  speciﬁc  to  PTSD,  were  also  indi-
vidually  predictive  of  adverse  outcome,  our  ﬁndings  suggest
[67
hat  components  unique  to  PTSD  added  to  poor  post-MI  prog-
osis  above  and  beyond  aspects  related  to  depression.
We  conclude  that  elevated  levels  of  PTSD  symptoms
aused  by  MI  may  increase  the  risk  of  future  cardiovascu-
ar  readmissions  in  post-MI  patients  suggesting  that  PTSD
aused  by  MI  is  an  important  clinical  entity.  Randomized
ontrolled  trials  seem  warranted  to  investigate  which  inter-
entions  effectively  reduce  PTSD  symptoms  caused  by  MI  and
hether  such  interventions  ultimately  improve  cardiovascu-
ar  outcome  in  post-MI  patients.
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